Search results

Please enter search term
Slaughter and May is advising GlaxoSmithKline - divestment of ofatumumab for auto-immune indications Slaughter and May is advising GlaxoSmithKline plc (GSK) on the divestment to Novartis of its rights in ofatumumab for auto-immune indications, including multiple sclerosis, for up to US$1 billion.
Slaughter and May advised CEMEX - refinancing and repayment of approximately US$1.94 billion Slaughter and May advised CEMEX on the refinancing and repayment of the total amount outstanding of approximately US$1.94 billion under its facilities agreement of September 2012 (the 2012 Financing Agreement) with new funds from seventeen financial...
Slaughter and May is advising Palamon Capital Partners and Corsair Capital - joint acquisition of Currencies Direct Slaughter and May is advising Palamon Capital Partners and Corsair Capital on their joint acquisition of Currencies Direct, a leading provider of currency exchange and international payment solutions to private and corporate clients.
Slaughter and May advised STAR Capital Partners Limited - £50m committed financing facility by Kennet Equipment Leasing Limited Slaughter and May advised STAR Capital Partners Limited, a leading European fund manager, on the entry into a £50m committed financing facility by Kennet Equipment Leasing Limited (Kennet).
Slaughter and May advised Dufry - competition aspects of acquisition of a 50.1% stake in global travel retailer World Duty Free S.p.A Slaughter and May, working as a team with Wachtell, Lipton, Rosen & Katz, Tozzini Freire and Jones Day, has been advising global travel retailer Dufry on the competition aspects of its acquisition of a 50.1% stake in global travel retailer World Duty Free...
Slaughter and May advised Coca-Cola Enterprises - agreement to combine with Coca-Cola Iberian Partners and CCEAG, to create Coca-Cola European Partners Slaughter and May advised Coca-Cola Enterprises, Inc. on its agreement to combine with Coca-Cola Iberian Partners and CCEAG, to create Coca-Cola European Partners, the world's largest independent Coca-Cola bottler based on net revenues.
Slaughter and May advised INEOS' joint venture, INOVYN - sale of assets to ICIG and establishment of joint venture with ICIG for membrane chlorine plant Slaughter and May advised INOVYN ChlorVinyls Limited (INOVYN) on its disposal of certain assets to International Chemical Investors Group (ICIG) and the establishment of a 50:50 joint venture with ICIG for a UK-based membrane chlorine plant.
Slaughter and May is advising Chime Communications - proposed acquisition by Bidco Slaughter and May is advising Chime Communications plc (Chime) on its acquisition by Bell Bidder Limited (Bidco), an entity controlled by funds managed by Providence Equity Partners.
Slaughter and May advised GKN - placing of shares Slaughter and May advised GKN plc (GKN) on the cashbox placing of up to approximately 5% of its existing issued ordinary share capital (the Placing) which raised gross proceeds of approximately £200 million
Slaughter and May is advising Hikma - acquisition of Roxane Slaughter and May is advising Hikma on its acquisition of Roxane